HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramon Farré Selected Research

Ramon Farré Research Topics

Disease

18Hypoxia (Hypoxemia)
07/2021 - 09/2009
12Neoplasms (Cancer)
01/2020 - 12/2012
10Sleep Apnea Syndromes (Sleep Apnea)
09/2021 - 01/2009
9Apnea
01/2019 - 09/2003
7Obstructive Sleep Apnea
06/2016 - 08/2002
4Airway Obstruction (Choking)
01/2019 - 06/2004
4Inflammation (Inflammations)
01/2019 - 01/2008
3Sleep Deprivation
11/2020 - 01/2019
3Heart Failure
01/2020 - 01/2018
2Chronic Obstructive Pulmonary Disease (COPD)
03/2022 - 01/2018
2Respiratory Tract Diseases (Respiratory Tract Disease)
07/2021 - 01/2018
2Lung Injury
07/2021 - 10/2012
2Obesity
01/2020 - 12/2012
2Melanoma (Melanoma, Malignant)
01/2018 - 05/2013
1Lung Diseases (Lung Disease)
04/2022
1Neuromuscular Diseases (Neuromuscular Disease)
03/2022
1Asthma (Bronchial Asthma)
03/2022
1Insulin Resistance
02/2021
1COVID-19
07/2020
1Dyspnea (Shortness of Breath)
01/2020
1Edema (Dropsy)
01/2020
1Primary Ovarian Insufficiency
01/2020
1Fatigue
01/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2020
1Overweight
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2019
1Suppuration
01/2018
1Vascular Remodeling
01/2018
1Adenocarcinoma of Lung
01/2017
1Lewis Lung Carcinoma
01/2017
1Adenocarcinoma
11/2016
1Sleep Wake Disorders
08/2016
1Aneurysm (Aneurysms)
01/2016
1Connective Tissue Diseases (Connective Tissue Disease)
01/2016
1Rupture
01/2016
1Marfan Syndrome (Marfan's Syndrome)
01/2016
1Carcinogenesis
11/2015
1Encephalitis (Encephalitis, Rasmussen)
10/2014
1Fibrosis (Cirrhosis)
09/2014
1Neoplasm Metastasis (Metastasis)
05/2013
1Necrosis
12/2012
1Acute Lung Injury
10/2012

Drug/Important Bio-Agent (IBA)

12Oxygen (Dioxygen)IBA
07/2021 - 09/2003
5Biological ProductsIBA
11/2020 - 09/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 12/2012
3salicylhydroxamic acid (SHAM)IBA
07/2014 - 07/2007
2CytokinesIBA
07/2021 - 02/2017
2Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2020 - 01/2019
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2019 - 01/2017
2EnzymesIBA
02/2017 - 07/2014
2MicroRNAs (MicroRNA)IBA
11/2016 - 08/2016
2Transcription Factors (Transcription Factor)IBA
06/2016 - 11/2015
2Bleomycin (Blenoxane)FDA LinkGeneric
09/2014 - 10/2012
2Proteins (Proteins, Gene)FDA Link
07/2014 - 10/2012
2platinum oxideIBA
07/2014 - 01/2010
2AntioxidantsIBA
07/2014 - 08/2011
1HydrogelsIBA
04/2022
1Bronchodilator Agents (Bronchodilators)IBA
03/2022
1SolutionsIBA
07/2021
116S Ribosomal RNAIBA
02/2021
1titanium dioxide (Titania)FDA Link
01/2019
1ferric oxide (iron oxide)IBA
01/2019
1LipopolysaccharidesIBA
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018
1Aligeron (AS 2)IBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018
1Dihydrotachysterol (AT 10)IBA
01/2018
1GasesIBA
01/2018
1Phenobarbital (Luminal)FDA Link
01/2018
1GasotransmittersIBA
01/2018
1Granzymes (Granzyme)IBA
02/2017
1InterferonsIBA
02/2017
1PerforinIBA
02/2017
1Celecoxib (Celebrex)FDA Link
01/2017
1Dinoprostone (PGE2)FDA Link
01/2017
1Messenger RNA (mRNA)IBA
08/2016
1Fibrillin-1IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Interleukin-6 (Interleukin 6)IBA
10/2014
1Gonadal Steroid Hormones (Sex Hormones)IBA
10/2014
1Interleukin-8 (Interleukin 8)IBA
10/2014
1Estrogens (Estrogen)FDA Link
10/2014
1MineralsIBA
12/2013
1LipidsIBA
12/2013
1ElementsIBA
12/2013
1Oxyhemoglobins (Oxyhemoglobin)IBA
07/2012

Therapy/Procedure

8Continuous Positive Airway Pressure
09/2021 - 08/2002
6Therapeutics
03/2022 - 02/2008
2Mechanical Ventilators (Ventilator)
07/2020 - 01/2020
2Ovariectomy (Oophorectomy)
01/2020 - 10/2014
1Critical Care (Surgical Intensive Care)
03/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
07/2021
1Fecal Microbiota Transplantation
02/2021
1Electrodes (Electrode)
01/2020
1Traction
01/2020
1Artificial Respiration (Mechanical Ventilation)
01/2018
1Aftercare (After-Treatment)
11/2016
1Intravenous Injections
05/2013